Abstract:The coronavirus disease 2019 (COVID-19) pandemic was caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus has challenged civilization and modern science in ways that few infectious diseases and natural disasters have previously, causing globally significant human morbidity and mortality and triggering economic downturns across financial markets that will be dealt with for generations. Despite this, the pandemic has also brought an opportunity for humanity to come together and participate in a shared scientific investigation. Clinically, SARS-CoV-2 is associated with lower mortality rates than other recently emerged coronaviruses, such as SARS-CoV and the Middle East respiratory syndrome coronavirus (MERS-CoV). However, SARS-CoV-2 exhibits efficient human-to-human spread, with transmission often occurring before symptom recognition; this feature averts containment strategies that had worked previ- ously for SARS-CoV and MERS-CoV. Severe COVID-19 disease is characterized by dysregulated inflammatory responses associated with pulmonary congestion and intravascular coagulopathy leading to pneumonia, vascular insults, and multiorgan disease. Approaches to treatment have combined supportive care with antivirals, such as remdesivir, with immunomodulatory medications, including corticosteroids and cytokine-blocking antibody therapies; these treatments have advanced rapidly through clinical trials. Innovative approaches to vaccine development have facilitated rapid advances in design, testing, and distribution. Much remains to be learned about SARS-CoV-2 and COVID-19, and further biomedical research is necessary, including comparative medicine studies in animal models. This overview of COVID-19 in humans will highlight important aspects of disease, relevant pathophysiology, underlying immunology, and therapeutics that have been developed to date.

COVID-19’s Pathways to Human Central Nervous System and Relevant Drug Treatment

Neurological and Psychiatric Presentations Associated with COVID-19

A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system

SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism

Neurological Manifestations of Patients with COVID-19: Potential Routes of SARS-CoV-2 Neuroinvasion from the Periphery to the Brain

Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms

COVID-19 and central nervous system interplay: A big picture beyond clinical manifestation

COVID-19: systemic pathology and its implications for therapy

COVID-19 and the nervous system

Nervous System Manifestations Related to COVID-19 and Their Possible Mechanisms

Potential of SARS-CoV-2 to Cause CNS Infection: Biologic Fundamental and Clinical Experience

The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients

Neurological complications caused by SARS-CoV-2

Severe Acute Respiratory Syndrome Coronavirus 2: Manifestations of Disease and Approaches to Treatment and Prevention in Humans

COVID-19 and Central Nervous System Manifestations: A Systemic review on Therapeutic Outcome

Neurological complications and infection mechanism of SARS-CoV-2

Central Nervous System Complications in SARS-CoV-2-infected Patients.

Neuropathogenesis of SARS-CoV-2 infection

COVID-19: Current Understanding of Pathophysiology

Brain Pathology in COVID-19: Clinical Manifestations and Potential Mechanisms

Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment.